Search Results for keywords:"epilepsy"

The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for 19 drivers who have experienced seizures and are on anti-seizure medication, allowing them to continue operating commercial motor vehicles despite the usual medical restrictions. These exemptions are granted because the drivers have shown they can safely operate vehicles, and each exemption is valid for two years. The drivers must follow specific conditions, like remaining seizure-free and undergoing regular medical examinations. If any safety issues arise, FMCSA may revoke these exemptions. FMCSA is also seeking comments from the public regarding these exemptions.

The Federal Motor Carrier Safety Administration (FMCSA) has issued a notice to correct a spelling error in a previous notice regarding the renewal of exemptions for 19 interstate commercial motor vehicle (CMV) drivers who have epilepsy or seizure disorders. These exemptions allow the drivers to operate CMVs despite having a history of seizures, as long as they meet certain conditions. Originally published on January 6, 2025, the misspelled name "Kieth Maat (KS)" has been corrected to "Keith Maat (KS)." This correction became effective as of March 27, 2025.

The Centers for Disease Control and Prevention (CDC) has announced a closed meeting scheduled for March 19, 2025. This meeting, which will be conducted via teleconference, will focus on reviewing and evaluating grant applications related to the incidence of epilepsy among children in the United States. The meeting is closed to the public due to the discussion of confidential information such as trade secrets and personal information. Dr. Catherine Barrett is the contact person for further information regarding the meeting.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to grant exemptions to 12 individuals from the rule that requires commercial motor vehicle drivers to have no medical history of epilepsy. These drivers, who have been seizure-free for extended periods while on a stable medication regimen, are permitted to operate vehicles across state lines. The FMCSA assessed each driver's medical background and determined they could potentially maintain a level of safety comparable to current regulations. The exemption is valid for two years, with specific terms and conditions, such as regular medical check-ups and immediate reporting of any seizures.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation (DOT), has announced a decision to renew a specific medical exemption for 10 truck drivers who have epilepsy or a history of seizures. These drivers, who take anti-seizure medication, are allowed to continue driving commercial vehicles across state lines. FMCSA found that renewing these exemptions maintains or improves safety levels compared to standard regulations. The exemptions are valid for two years unless revoked earlier based on specific conditions not being met.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for ten individuals, allowing them to drive commercial motor vehicles even though they have epilepsy or seizure disorders, as long as they remain seizure-free and under stable treatment. These exemptions are valid for two years and enable the individuals, who are on anti-seizure medication, to continue working in interstate commerce. FMCSA ensures ongoing safety through annual medical reports and examinations, and while the exemption is in effect, states cannot enforce conflicting laws against these drivers. If any conditions are not met or if safety is compromised, the exemptions can be revoked.

The Federal Motor Carrier Safety Administration (FMCSA) has received applications from 12 individuals seeking exemptions from a rule that generally prohibits people with epilepsy or related conditions from driving commercial motor vehicles (CMVs) in interstate commerce. These individuals, who have had seizures but are currently under medication and seizure-free, want to be allowed to drive CMVs. The FMCSA is evaluating their qualifications and inviting public comments on these exemption requests by January 27, 2025. This notice reflects ongoing efforts to balance regulatory safety standards with opportunities for drivers managing medical conditions to legally operate CMVs.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation, is considering granting exemptions for 32 individuals who have a history of epilepsy or seizure disorders, allowing them to drive commercial motor vehicles across state lines. These individuals are currently taking medication and have been seizure-free for a significant period. FMCSA requests public comments on these exemption requests to ensure they meet safety requirements and provide an equivalent or higher level of safety than current regulations. The agency will review each applicant’s medical history and driving record before deciding.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for 10 individuals who have a history of epilepsy or seizures. Normally, drivers with such medical history are not allowed to operate commercial motor vehicles (CMVs) in interstate commerce due to safety regulations. However, these exemptions allow the individuals to continue driving as long as they are on anti-seizure medication, ensuring safety is equivalent to standard regulations. The exemptions are valid for two years from their effective date but can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for seven drivers who have epilepsy or seizure disorders, allowing them to continue driving commercial motor vehicles across state lines. These exemptions, effective from August 31, 2024, to August 31, 2026, were granted after the FMCSA determined that they would maintain or exceed safety standards for drivers. Despite public invitations for comments, no feedback was received during the review periods. Each exemption will last two years unless revoked due to non-compliance, decreased safety, or inconsistency with regulatory goals.